Fall 2011

Glenn Preminger, MD 2011

Glenn M. Preminger, MD

James F. Glenn, MD Professor of Urology

Chief, Division of Urologic Surgery 


Message From the Chief


It is with unbounded enthusiasm that I welcome you to the Duke Urology Fall 2011 E-Newsletter. It's been a whirlwind 2 months in my new position, and I have loved every minute. I'd like to thank Judd Moul, MD for his stewardship of Duke Urology over the last 7 years. Judd plans to remain at Duke as the James H. Semans, MD Professor of Urology and Director of the Duke Prostate Center.


We've had a busy 2011. Our Duke Urology residents, fellows and faculty had excellent participation at the SESAUA meeting in New Orleans in April and the AUA meeting in Washington, DC in May. In addition, one of the most exciting events in our residency program was the Urology RRC approval of a 4th resident slot, beginning July 2012. Over the next few years, we will grow the program to 20 residents.

June saw the graduation of our three chief residents, Joe Klink, Chuck Scales and Florian Schroeck. They each contributed significantly to Duke Urology, and I believe they will have an impressive impact in academic Urology in the near future. I have communicated with each of them since graduation, and they all are happy in their respective fellowships.


We began a new tradition this year at the Graduating Chief's Dinner. We sent a special invitation to the 5th and 25th graduating classes and welcomed 5th year DYSURIC Matt Young from Athens, Georgia and 25th year DYSURICs Michael Brown from Huntsville, Alabama; Robert Bertram from Salisbury, NC; and John Nesbitt from Glasgow, Kentucky to a wonderful evening at the Washington-Duke Inn and Golf Club. In addition, we inaugurated the first Duke Urology Resident-Faculty-Alumni golf tournament on Saturday morning. We anticipate that this new tradition will encourage new and "old" DYSURICs to attend the Chiefs' Dinner to honor our graduating Chiefs and to reminisce with friends and colleagues. Please save Friday, June 22 to attend the 2012 Chiefs' Dinner at the Washington-Duke. We will have more detailed information on this event in our Winter 2012 E-Newsletter.


19th Hole-Golf 2011  

Golf Outing Group - June 2011 


I was profoundly honored in July to be named the James F. Glenn, MD Distinguished Professor of Urology. This recognition was particularly meaningful to me as I personally knew Jim Glenn over the years when I was a medical student, resident and faculty member.   Duke Urology now has two endowed professorships, as Judd Moul currently holds the Semans Professorship.

Another exciting highlight of the year was the opening of our new Duke Urology of Raleigh practice on the campus of Duke Raleigh Hospital in early July. Led by Cary Robertson, MD, the Duke Raleigh practice will provide general Urology and sub-specialty care for patients in Raleigh and points east. We are very excited to have such a strong presence in Wake County.

Duke Urology of Raleigh Staff-2011 

(l to r) Aaron C. Lentz, MD, Helen Tackitt, FNP, Michael E. Lipkin, MD, Cary N. Robertson, MD

(Program Director, Duke Urology of Raleigh) and Charles J. Viviano, MD, PhD



We also welcomed four new faculty members over the Summer. Charles Viviano, MD, PhD and Aaron Lentz, MD have joined the Duke Raleigh practice, focusing on general and reconstructive Urology, respectively. Mike Lipkin, MD has joined me in running the Duke Stone Center and will split his time between Duke Raleigh and Duke Hospital in Durham. Jonathan Routh, MD is now the third member of our Duke Pediatric Urology program, focusing on robotic surgery and outcomes research.


Since the start of the year, we have welcomed two new advanced practice providers to assist our faculty and see patients independently. Jessica Clark, PA and Sarah Sebastian, PA are exciting additions to our Duke Urology Team. We are also excited to announce that Sarah Yttri, NP, will join our ranks in December. Sarah previously worked as an RN at Duke Hospital and recently graduated from the Nurse Practitioner program at Duke.


We have had some changes in our long-standing Senior Staff this year. Craig Donatucci, MD recently retired from Duke to become the Director of Men's Health for Eli Lilly Pharmaceuticals. Craig has been with Duke Urology for 18 years. He served a term as interim chief and has consistently served the Division well in various other leadership roles. We wish him well in his new position. Phil Walther, MD has also retired his Duke clinical practice to focus his efforts as Chief of the Urology Service at the Durham VA Medical Center. We are pleased that our residents will continue to benefit from Phil's excellent teaching methods.


We anticipate a busy Fall, getting ready for the WCE, SUO, SESAUA and AUA meetings later this year and early next year. We are also in the process of recruiting new faculty members to strengthen our programs in Urologic Oncology, Female Urology and Andrology. I anticipate introducing new faculty members to you in our next newsletter.


Again, it is an honor to help guide our knowledgeable, innovative and compassionate group of residents, fellows, faculty and staff. I believe great things are in store for Duke Urology as we open the new Duke Cancer Institute  in February and the Duke Medical Pavilion in 2013 . Please drop me a note or come by to see us in Durham. I look forward to speaking with you.


All the best,




 Welcome, New Faculty


Aaron C. Lentz, MD-2011
Aaron C. Lentz, MD

Training: MD, University of North Carolina at Chapel Hill School of Medicine, 2005; Residency, Urologic Surgery, University of North Carolina Hospitals, 2005-2010; Fellowship, Reconstructive Urology, Female Urology, and Urodynamics, Duke University Medical Center, 2010-2011

Clinical Interests: Reconstructive urology with a specific focus on minimally invasive approaches to urethral stricture disease, urinary incontinence, ureteral obstruction, fistula repair, genitourinary trauma, sexual dysfunction, prostate enlargement, and videourodynamic evaluation










Michael E. Lipkin, MD-2011

Michael E. Lipkin, MD

Training: MD, University of Medicine and Dentistry of New Jersey-New Jersey Medical School, 2003; Residency, Urology, New York University Medical Center, 2009; Fellowship, Endourology, Laparoscopy, and Robotics, Duke University Medical Center, 2011

Clinical Interests: Medical and surgical management of kidney stone disease, minimally invasive urologic surgery, endoscopic management of urinary tract obstruction, robotic and laparoscopic urologic surgery












Jonathan C. Routh, MD, MPH-2011























Jonathan C. Routh, MD, MPH

Training: MD, University of North Carolina at Chapel Hill School of Medicine, 2002; Residency, Urology, Mayo Clinic, 2008; Fellowships, Pediatric Health Services Research, Harvard Medical School, 2010, Pediatric Urology, Children's Hospital Boston, 2011; Other Training: Masters of Public Health, Harvard School of Public Health, 2010

Clinical Interests: Reconstructive surgery of congenital anomalies of the genitourinary tract (hypospadias, cryptorchidism, intersex, obstructive uropathies [hydronephrosis], vesicoureteral reflux, exstrophy); management of urinary-tract infections, incontinence, and enuresis in children, management of neurogenic bladders in children; general pediatric urology; consultation for fetal uropathies; urologic neoplasms in children


Charles J. Viviano, MD, PhD-2011

Charles J. Viviano, MD, PhD

Training: MD, University of Connecticut School of Medicine, 2000; Residency, Urology, University of Connecticut Health Center, 2000-2006; Other Training: PhD, Toxicology, University of North Carolina at Chapel Hill, 1994

Clinical Interests: General adult urology including kidney stones, BPH, hypogonadism, erectile dysfunction, hematuria, vasectomy


Current Fellows:


Endourology, Metabolic Stone Disease, Laparoscopic and Robotic Surgery:

Iqbal W. Muhammad, MD

Agnes J Wang, MD


GU Cancer Survivorship:

                Raymond M. Bernal, MD


Reconstructive Urology, Female Urology and Urodynamics:

                Joshua M. Lohri, MD


Urologic Oncology:

                Michael R. Abern, MD



Current Advanced Practice Providers:


Shelby L. Barthel, RN, MSN, ANP-BC

Adult Nurse Practitioner

Training:Duke University, Adult Nurse Practitioner-Primary Care, 2009

Interests:  General urology in the adult & geriatric populations, urologic oncology, prostate cancer survivorship


Sarah Sebastian, PA-C

Physician Assistant

Training: George Washington University, 2010

Interests: Reconstructive urology, urinary incontinence, urethral stricture disease, erectile dysfunction, Peyronie's disease, and hypogonadism


Helen Tackitt FNP-BC, HCA

Nurse Practitioner and Practice Manager, Duke Urology of Raleigh

Training: Regis University, Denver, CO, 2006

Interests: BPH, incontinence, general urology


Jessica Clark, PA-C

Physician Assistant

Training: King's College, Wilkes Barre, PA, 2006

Interests: Surgical and medical management of urological cancers, obstructive uropathy, men's health, outpatient postoperative care, and PA education.


Cynthia J. Camille, FNP-BC, CPNP

Pediatric Urology Nurse Practitioner

Training: BSN, University of Iowa, 1975

PNP, University of Iowa, 1980

MSN, FNP, Duke University, 1999

Interests:  Voiding dysfunction, incontinence, enuresis, neurogenic bladder, spina bifida, hydronephrosis, vesicoureteral reflux, urinary tract infections, urodynamics, biofeedback for pelvic floor dysfunction, prenatal consultation for urinary tract abnormalities, patient and family education.


Thomas A. Esther, PA-C

Physician Assistant

Training: Howard University, 1997

Interests: Prostate cancer, BPH, erectile dysfunction, post prostatectomy incontinence , hypogonadism, Peyronie's disease


Duke Pediatric Urology Update


The Section of Pediatric Urology expanded to three urologists this past July:


John S. Wiener, M.D. trained in Urology at Duke and pediatric urology at Texas Children's Hospital in Houston under fellow DYSRUIC Edmond Gonzales. Dr. Wiener has been Head of the Pediatric Urology section since 1997-2003 and 2005-present. His primary research interest is in the care of spina bifida patients, and he was recently awarded a three year grant from the Centers for Disease Control and Prevention to enroll the Duke Comprehensive Spina Bifida Clinic as a pilot center in the National Spina Bifida Patient Registry.


Sherry S. Ross, M.D came to Duke in 2009 after completing her residency and fellowship at Children's National Medical Center/George Washington University in Washington DC. Dr. Ross is a native of Troy, NC and is a graduate of East Carolina University and the University of North Carolina School of Medicine. Her primary research interest is in the study of urinary tract infections in neurogenic bladder, and her work in developing a rat model with Duke Urology resident Zarine Balsara, M.D., Ph.D. won Dr. Balsara the first AUA Russell Scott Jr. Resident Research Award in 2010. Dr. Ross is also working with other centers to set up PediUro - a multi-institutional collaborative to prospectively study pediatric urologic issues. Dr. Ross is Director of the Undergraduate Urologic Studies (for medical students), Pediatric Urology Research, and the Pediatric Stone Clinic at Duke.


Jonathan C. Routh, M.D., MPH began at Duke this summer after completing his fellowship at Boston Children's Hospital and earning a M.P.H. at Harvard University. Dr. Routh is a native of Raleigh, NC and graduated from NC State University and the University of North Carolina School of Medicine. He received his urology training at The Mayo Clinic in Rochester, MN. His primary research interest is in health services (outcomes) research, and he has an appointment at the Duke Clinical Research Institute. He is also bringing his experience in robotic surgery in infants and children to Duke and developing a program in minimally invasive surgery in pediatric urology with the assistance of Dr. Ross.


In addition to routine pediatric urology care, we have specialty clinics including the Duke Pediatric Stone Clinic (staffed by urologists, nephrologists, a dietician, and an endocrinologist), the Duke Comprehensive Spina Bifida Clinic (with urologists, neurosurgeons, orthopedists, developmental pediatricians, and allied professionals), and the Achieving Bladder Control at Duke (ABCD Clinic) run by Cynthia Camille, CFNP. We see patients in multiple locations in Durham, Raleigh, and Greensboro and perform surgery in Durham and Raleigh.



Updates from the Vice Chiefs


Andrew C. Peterson, MD, FACS

Clinical Operations:


The last year has been an exceedingly productive year for clinic 1G! Throughout this time we have seen multiple changes with respect to the facilities, how we deliver patient care, and how we staff the clinic. We have implemented the patient screening rooms and currently have two in full practice at all times. This has resulted in an improvement in the patient throughput of the clinic as well as utilization of rooms. We implemented the Tele-Health nurse service several months ago, starting with one provider on a full-time basis. After monitoring the call volume we've now added a full-time second Tele-Health nurse in order to provide this service to our patients. In addition to those changes we have been attempting to solidify the team aspect to clinic 1G, ensuring that the same team works with each physician during their clinic hours (obviously staffing issues mandate daily monitoring of this and changes).


With these changes we have seen a significant improvement in both patient satisfaction, ability to serve our providers, and improve access to the clinic. Over the last year patient satisfaction scores have significantly improved; and clinic 1G now consistently ranks in the top five clinics with respect to patient satisfaction on a weekly basis.


There are too many other positive things to report in this newsletter, needless to say we are extremely proud of our clinic and honored to practice in such an outstanding facility. Thank you to all those who make this possible, the nursing staff, the nursing leadership, the physician providers and all of the mid-level providers! We hope to make clinic 1G an even more enjoyable and rewarding place to work in 2012 as it continues to establish itself as the best clinic in the Duke system!



John S. Wiener, MD



Residency: We are excited to report that the Residency Review Committee of the Accreditation Council for Graduate Medical Education approved Duke Urology to expand to four residency slots per year beginning in 2012. Therefore, we are planning to take four interns in the upcoming application process. This is the sixth year that the Department of Defense has contracted with Duke Urology to identify one residency slot for a future Army urologist, and chief resident Dr. Danielle Stackhouse will be our first graduate from this collaboration. The expansion to four residents per year will allow us to have more residents at Duke Hospital which is opening a new Cancer Center in 2012 and hospital addition in 2013 (Duke Medical Pavilion - 16 new ORs, 96 critical care beds, and 64 intermediate care beds. ) In addition, we will eventually send two residents to Duke Raleigh Hospital to work with our four urologists there.


Post-Graduate Education:

Duke Tuesday in Urology

For the past 34 years, the Duke Tuesday program has brought together visiting professors, Duke Urology faculty, and urologists across the region for an afternoon of CME activities three days a year. Our future speakers include:

                November 15, 2011 - Dr. Claus Roehrborn - UT Southwestern Medical Center

                February 7, 2012 - Dr. Alan Retik - Children's Hospital of Boston/Harvard University


Duke Urologic Assembly

The 44th annual Duke Urologic Assembly will return to the western United States at the Arizona Biltmore in Phoenix, Arizona on April 19-22, 2012. Be on the lookout for program details.


Duke Prostate Center Symposium

We conducted our 7th annual Duke Prostate Center Symposium on September 16-17, 2011 at the Washington-Duke Inn in Durham. Both local and outside experts spoke at this CME event and patient symposium. One hundred seventeen attended the CME program, and 60 patients and advocates were present for the symposium.


International Symposium on Focal Therapy and Imaging in Prostate and Kidney Cancer

This fifth collaboration between Duke Urology, the University of Southern California, and AMC Amsterdam will be held June 6-8, 2012 at the Washington-Duke Inn in Durham. More details are available at http://www.focaltherapy.org.



Stephen J. Freedland, MD



Duke Urology research continues to be strong. A recent report card of the research productivity of various academic Urology centers in the US ranked Duke Urology as the 8th most productive group in the country (http://hospitalacademicrank.com/). This is not due to the productivity of one single person or one group, but rather is a testament to the broad strength of Duke Urology's research efforts. As such, it is not possible to highlight all the research areas that make Duke Urology so strong. Thus, for this Newsletter, we are going to highlight just 3 areas: prostate cancer, stone disease, and pediatric urology. Future newsletters will highlight the other areas of research strength.


A key area of expertise within Duke Urology lies in prostate cancer. Specific areas of interest include novel prostate cancer therapies, risk stratification, and the role of metabolism/lifestyle factors in influencing prostate cancer growth. The Duke Prostate Center continues to lead the way with innovative studies addressing which patients need the most aggressive therapy. Moreover, as we anticipate moving into the new Duke Cancer Institute clinic space early in 2012 where clinic space will be combined with our Medical and Radiation Oncology colleagues, we have begun to explore the outcomes of our patients who initially presented to Duke through our Multi-Disciplinary Clinic (MDC). In our initial analyses lead by one of our residents, Dr. Suzanne Stewart with the help of Drs. Lionel Banez (Assistant Professor of Urology) and Judd Moul (Professor of Urology), we found that patients who came through the MDC travelled farther than patients who just saw a Urologist at Duke. This suggests that the word is out and people are coming from long distances to be seen at Duke through a multidisciplinary approach to clinical care. Other advances from the laboratory of Dr. Stephen Freedland (Associate Professor of Urology) include recent findings that low-carbohydrate diets and statins to lower cholesterol, may both slow prostate cancer growth - at least in animal models. Human studies are either underway or preparing to start in the near future.


In regards to stone disease, work continues on two major fronts: 1) lowering the radiation dose needed to accurately diagnose a stone, lead by Drs. Michael Ferrandino, Michael Lipkin, and Glenn Preminger and 2) optimizing the lenses used to focus shock waves to maximally break up the stones under the leadership of Drs. Glenn Preminger and Pei Zhong. Work from Duke has shown that lower doses of radiation are safe, result in similar stone detection rates, and may well be the future of stone diagnosis.


With regards to pediatric urology research, to date the focus has been on preventing urinary tract infections in children with poorly functioning bladders - a common issue in children with spinal cord problems. However, before effective therapies could be tested, an animal model needed to be developed. Lead by one of our residents, Dr. Zarine Balsara, under the leadership of Drs. Sherry Ross (Assistant Professor of Urology), Patrick Seed (Assistant Professor of Pediatrics), and Paul Dolber (Associate Professor of Surgery), the work has developed a viable animal model that develops a poorly functioning bladder and is thus more susceptible to urinary tract infections. Now the researchers are poised to begin testing different treatments and preventative agents for urinary tract infection which hopefully will one day be useful in the clinic to reduce the suffering of our youngest patients.


In summary, Duke Urology research remains strong. Though challenges remain especially in this highly regulated and under-funded environment, the perseverance of Duke Urology has resulted in great strides. We are excited about the future and continuing to translate today's research into tomorrow's practice.




Congratulations, Graduates


2010 Graduates

2010 Graduates

(l to r) Marnie R. Robinson, MD, Glenn M. Preminger, MD (Program Director), W. Cooper Buschemeyer III, MD, Edward R. Rampersaud, MD



Marnie Robinson is currently in private practice at Chesapeake Urology Associates in Owings Mills, Maryland.  W. Cooper Buschemeyer is in private practice at Allied Urology in Louisville, Kentucky.  

Ed Rampersaud is completing a urologic oncology fellowship at UCLA in Los Angeles, California.



2011 Graduates 

2011 Graduates

 (l to r) Florian R. Schroeck, MD, Charles D. Scales Jr, MD, Joseph C. Klink, MD


Florian Schroeck is completing a urologic oncology fellowship and health services research fellowship at the University of Michigan.  Chuck Scales is completing a fellowship at the Robert Woods Johnson Clinical Scholars Program at UCLA.  Joseph Klink is completing a urologic oncology fellowship at the Cleveland Clinic.



Current Residents:


Chief Residents:

Jodi Antonelli, MD

Erin R. McNamara, MD

Danielle A. Stackhouse, MD


Senior Residents (PGY-5):

John G. Mancini, MD

Suzanne B. Stewart, MD

Brian M. Whitley, MD


Senior Residents (PGY-4):

Mark R. Anderson, MD

Zarine Balsara, MD, PhD

David I, Chu, MD


Laboratory Residents (PGY-3):

Rajeev Chaudhry, MD

Zachariah Goldsmith, MD

Abhay A. Singh, MD


Junior Residents (PGY-2):

Jessica C. Lloyd, MD

Ramiro Madden-Fuentes, MD

Nicholas Kuntz, MD


Interns in General Surgery (PGY-1):

Michael A. Granieri, MD

Richard H. Shin, MD

Tara Ortiz, MD


Recent Publications: 


Arvold ND, Chen M-H, Moul JW, Moran BJ, Dosoretz DE, Baņez LL, Katin MJ, Braccioforte MH, D'Amico AV.

Risk of Death From Prostate Cancer After Radical Prostatectomy or Brachytherapy in Men with Low or Intermediate Risk Disease.

J Urol 186:91-96, July 2011.


Tang P, Sun L, Uhlman MA, Robertson CN, Polascik TJ, Moul JW.

Prostate-Specific Antigen Velocity Based Risk-Adapted Discontinuation of Prostate Cancer Screening in Elderly Men.

BJU Int. 108(1): 44-48, July 2011.


Moreira DM, Anderson T, Gerber L, Thomas JA, Baņez LL, McKeever MG, Hoyo C, Grant D, Jayachandran J, Freedland SJ.

The Association of Diabetes Mellitus and High-Grade Prostate Cancer in a Multiethnic Biopsy Series.

Cancer Causes Control 22(7): 977-983, July 2011.


Lammers RJ, Witjes JA, Inman BA, Leibovitch I, Laufer M, Nativ O, Colombo R.

The Role of a Combined Regimen with Intravesical Chemotherapy and Hyperthermia in the Management of Non-Muscle-Invasive Bladder Cancer: A Systematic Review.

Eur Urol. 60(1): 81-93, July 2011.


Scales CD Jr, Krupski TL, Curtis LH, Matlaga B, Lotan Y, Pearle MS, Saigal C, Preminger GM; Urologic Diseases in America Project.

Practice Variation in the Surgical Management of Urinary Lithiasis.

J Urol. 186(1): 146-150, July 2011.


Routh JC.

Editorial Comment.

Urology 78(1): 152-153, July 2011.


Wiener JS, Antonelli J, Shea AM, Curtis LH, Schulman KA, Krupski TL, Scales CD Jr.

Bladder Augmentation Versus Urinary Diversion in Patients with Spina Bifida in the United States.

J Urol 186(1): 161-165, July 2011.


Scales Jr CD, Canfield SE.

Advanced Topics in Evidence-Based Urological Oncology: Using Results of a Subgroup Analysis.

Urol Oncol. 29(4): 462-466, July-August 2011.


Lipkin ME, Mancini JG, Simmons WN, Raymundo ME, Yong DZ, Wang AJ, Ferrandino MN, Albala DM, Preminger GM.

Pathologic Evaluation of Hemostatic Agents in Percutaneous Nephrolithotomy Tracts in a Porcine Model.

J Endourol. 25(8): 1353-1357, August 2011.


 Ploussard G, Epstein JI, Montironi R, Carroll PR, Wirth M, Grimm MO, Bjartell AS, Montorsi F, Freedland SJ, Erbersdobler A, van der Kwast TH.

The Contemporary Concept of Significant versus Insignificant Prostate Cancer.

Eur Urol 60(2): 291-303, August 2011.


Kimura M, Yan H, Rabbani Z, Satoh T, Baba S, Yin FF, Polascik TJ, Donatucci CF, Vujaskovic Z, Koontz BF.

Radiation-Induced Erectile Dysfunction Using Prostate-Confined Modern Radiotherapy in a Rat Model.

J Sex Med 8(8): 2215-2226, August 2011.


Lipkin ME, Mancini JG, Simmons WN, Raymundo ME, Yong DZ, Wang AJ, Ferrandino MN, Albala DM, Preminger GM.

Pathologic Evaluation of Hemostatic Agents in Percutaneous Nephrolithotomy Tracts in a Porcine Model.

J Endourol 25(8): 1353-1357, August 2011.


Tsivian M, Caso J, Kimura M, Polascik TJ.

Renal Function Outcomes after Laparoscopic Renal Cryoablation

J Endourol 25(8): 1287-1291, August 2011.


Tsivian M, Polascik TJ.

The Role of Transrectal Saturation Biopsy in Tumor Localization: Pathological Correlation after Retropubic Radical Prostatectomy and Implication for Focal Ablative Therapy.

BJU Int. 108(3): 371, August 2011.


Routh JC, Graham DA, Estrada CR, Nelson CP.

Contemporary Use of Nephron-Sparing Surgery for Children with Malignant Renal Tumors at Freestanding Children's Hospitals.

Urology 78(2): 422-426, August 2011.


Husmann DA, Routh JC, Hagerty JA, Cannon GM, Gomez P, Cheng EY, Skoog S.

Evaluation of the United States Pediatric Urology Workforce and Fellowships: A Series of Surveys Performed in 2006-2010.

J Pediatr Urol. 7(4): 446-453, August 2011.


Armstrong AJ, Marengo MS, Oltean S, Kemeny G, Bitting RL, Turnbull JD, Herold CI, Marcom PK, George DJ, Garcia-Blanco MA.

Circulating Tumor Cells from Patients with Advanced Prostate and Breast Cancer Display both Epithelial and Mesenchymal Markers.

Mol Cancer Res. 9(8): 997-1007, August 2011.


Bitting RL, Madden J, Armstrong AJ.

Therapy for Non-Clear Cell Histologies in Renal Cancer.

Curr Clin Pharmacol. 6(3): 169-180, August 2011.


Sonpavde G, Pond GR, Berry WR, de Wit R, Eisenberger MA, Tannock IF, Armstrong AJ.

The Association Between Radiographic Response and Overall Survival in Men With Metastatic Castration-Resistant Prostate Cancer Receiving Chemotherapy.

Cancer 117(17): 3963-3971, September 2011.


Antonarakis ES, Armstrong AJ.

Emerging Therapeutic Approaches in the Management of Metastatic Castration-Resistant Prostate Cancer.

Prostate Cancer Prostatic Dis. 14(3): 206-218, September 2011.


Antonarakis ES, Armstrong AJ.

Evolving Standards in the Treatment of Docetaxel-Refractory Castration-Resistant Prostate Cancer Prostatic Dis. 14(3): 192-205, September 2011.


Crawford ED, Tombal B, Miller K, Boccon-Gibod L, Schroder F, Shore N, Moul JW, Jensen J-K, Olesen TK, Persson.

A Phase III Extension Trial with a 1-Arm Crossover from Leuprolide to Degarelix: Comparison of Gonadotropin-Releasing Hormone Agonist and Antagonist Effect on Prostate Cancer.

J Urol 186(3):889-897, September 2011.


Tsivian A, Tsivian M, Sidi AA.

Laparoendoscopic Single-Site Repair of Incisional Hernias after Urological Surgery

Urology 78(3): 715-718, September 2011.


Kim HS, Moreira DM, Jayachandran J, Gerber L, Baņez LL, Vollmer RT, Lark AL, Donovan MJ, Powell D, Khan FM, Freedland SJ.

Prostate Biopsies from Black Men Express Higher Levels of Aggressive Disease Biomarkers than Prostate Biopsies from White Men.

Prostate Cancer Prostatic Dis. 14(3): 262-265, September 2011.


Hamilton RJ, Freedland SJ.

5-Alpha Reductase Inhibitors and Prostate Cancer Prevention: Where do we Turn Now?

BMC Med. 9(1): 105, September 2011.


Yong DZ, Lipkin ME, Simmons WN, Sankin G, Albala DM, Zhong P, Preminger GM.

Optimization of Treatment Strategy used During Shockwave Lithotripsy to Maximize Stone Fragmentation Efficiency.

J Endourol. 25(9): 1507-1511, September 2011.


Cotter SE, Chen MH, Moul JW, Lee WR, Koontz BF, Anscher MS, Robertson CN, Walther PJ, Polascik TJ, D'Amico AV.

Salvage Radiation in Men after Prostate-Specific Antigen Failure and the Risk of Death.

Cancer 117(17): 3925-3932, September 2011.


Skolarikos A, Gravas S, Laguna MP, Traxer O, Preminger GM, de la Rosette J.

Training in Ureteroscopy: A Critical Appraisal of the Literature.

BJU Int. 108(6): 798-805, September 2011.


Hall SJ, Klotz L, Pantuck AJ, George DJ, Whitmore JB, Frohlich MW, Sims RB.

Integrated Safety Data from 4 Randomized, Double-Blind, Controlled Trials of Autologous Cellular Immunotherapy with Sipuleucel-T in Patients with Prostate Cancer.

J Urol 186(3): 877-881, September 2011.


Harrison MR, George DJ.

Better Late than Early: FDG-PET Imaging in Metastatic Renal Cell Carcinoma.

Clin Cancer Res. 17(18): 5841-5843, September 2011.


Motzer RJ, Agarwal N, Beard C, Bhayani S, Bolger GB, Carducci MA, Chang SS, Choueiri TK, Hancock SL, Hudes GR, Jonasch E, Josephson D, Kuzel TM, Levine EG, Lin DW, Margolin KA, Michaelson MD, Olencki T, Pili R, Ratliff TW, Redman BG, Robertson CN, Ryan CJ, Sheinfeld J, Spiess PE, Wang J, Wilder RB.

Kidney Cancer.

J Natl Compr Canc Netw. 9(9): 960-977, September 2011.


Stewart SB, Freedland SJ.

Influence of Obesity on the Incidence and Treatment of Genitourinary Malignancies.

Urol Oncol. 29(5): 476-486, September-October 2011.






John S. Wiener, MD, Pediatric Urology, has been awarded a three year grant from the Centers for Disease Control and Prevention to participate in a pilot project for a National Spina Bifida Patient Registry.


Judd W. Moul, MD has been reappointed to a second term for the American Joint Committee on Cancer.


Zarine Balsara, MD, PhD won first prize for her research presentation at the 11th annual N.C. Urology Resident Symposium at the Grandover Resort in Greensboro, NC, September 10, 2011.


Mark Anderson, MD won third prize for his research presentation at the 11th annual N.C. Urology Resident Symposium at the Grandover Resort in Greensboro, NC, September 10, 2011.


Erin McNamara, MD and Zach Goldsmith, MD were winners for their urologic debates at the 11th annual N.C. Urology Resident Symposium at the Grandover Resort in Greensboro, NC, September 10, 2011.



Save the Dates:


Duke Tuesday in Urology 

November 15, 2011 - Searle Conference Center, Duke University Medical Center, Durham, NC

Guest Lecturer: Claus G. Roehrborn, MD, UT Southwestern Medical Center


Duke Tuesday in Urology 

February 7, 2012 - Searle Conference Center, Duke University Medical Center, Durham, NC

Guest Lecturer: Alan B. Retik, MD, Children's Hospital of Boston/Harvard Medical School


Duke Urologic Assembly 

April 19-22, 2012

Arizona Biltmore, Phoenix, Arizona


International Symposium on Focal Therapy & Imaging in Prostate and Kidney Cancer 

June 6-8, 2012

Washington-Duke Inn, Durham, NC


Graduating Chief's Dinner

June 22, 2012

Duke Urology Resident-Faculty-Alumni Golf Tournament

June 23, 2012

Washington-Duke Inn, Durham, NC


Quick Links...